A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to find out the highest dose per fraction of hypofractionated
Intensity-Modulated Radiation Therapy (Hypo-IMRT) that can be safely given with temozolomide
chemotherapy.